Daily Mail on South Dakota US STOCKS-Apple, energy shares drag Wall St lower amid China COVID protests South Dakota Non-Local Sources • Nov 28, 2022
Rapid City Journal The FDA approved a new drug to treat Alzheimer's, but Medicare won't always pay for it -- a doctor explains what researchers know about Biogen's Aduhelm Southwest South Dakota • Apr 14, 2022
Mitchell Daily Republic Facing headwinds on new Alzheimer's drug, Biogen launches controversial campaign Southcentral South Dakota • Jul 26, 2021
Argus Leader Sioux Falls FDA approves new Alzheimer's drug, Aduhelm, the first in nearly two decades Southeast South Dakota • Jun 7, 2021
Mitchell Daily Republic U.S. FDA panel votes cannot ignore unsuccessful trial data on Biogen Alzheimer's drug Southcentral South Dakota • Nov 6, 2020
South Dakota AG Connection Ag State Colleagues Call for Biogenic Carbon Emission Clarity South Dakota Business • Nov 20, 2019
South Dakota War College Rounds and Thune Join Colleagues to Call on EPA to Provide Clarity on Biogenic Carbon Emissions South Dakota Politics • Nov 19, 2019